Interleukin-1- and Type I Interferon-Dependent Enhanced Immunogenicity of an NYVAC-HIV-1 Env-Gag-Pol-Nef Vaccine Vector with Dual Deletions of Type I and Type II Interferon-Binding Proteins
Julie Delaloye(University Hospital of Lausanne), Thierry Calandra(University of Lausanne)
Cited by 13
Related Papers
Macrophage migration inhibitory factor: a regulator of innate immunity
|Nature reviews. Immunology|2003|1.8k